Allogene Therapeutics ALLO
NASDAQ ALLO
$1.26 -0.07 (-4.89%)
As of: Oct 22, 2026 · 12:51 PM EDT

Allogene Therapeutics (ALLO) Short-term Investments (2018 - 2026)

Updated

Allogene Therapeutics (ALLO) recorded Short-term Investments of $293.98 million in Q2 2026, up 33.1% from $220.79 million a year earlier and up 24.3% from the prior quarter.

Analysis

Allogene Therapeutics (ALLO) Short-term Investments (2018 - 2026) Analysis & Trends

At the end of FY2025, Allogene Therapeutics reported Short-term Investments of $198.52 million, down 8.6% from FY2024.

  • Annual Short-term Investments has declined for three straight years, with a five-year compound annual growth rate of -21.0% (FY2020 to FY2025).
  • Across earlier years, Short-term Investments came in at $217.26 million in FY2024 (-40.6%), $365.54 million in FY2023 (-19.7%), $455.42 million in FY2022 (+60.4%) and $283.99 million in FY2021 (-55.9%).
  • The Q2 2026 figure is the highest quarterly Short-term Investments since Q1 2024.
  • On a year-over-year basis, Short-term Investments rose in 1 of the last eight quarters, with an average decline of 14.4%.
  • Peak year-over-year performance for Short-term Investments in the last five years was growth of 62.8% in Q3 2022, against a decline of 57.0% in Q3 2021 at the low end.
  • Per Business Quant, the preceding three quarters came in at $236.58 million (Q1 2026), $198.52 million (Q4 2025) and $214.38 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,168.10 Bn 1,136.68 Bn 19.71 Bn
2 Johnson & Johnson 643.43 Bn 561.95 Bn 17.26 Bn
3 AbbVie 500.92 Bn 474.03 Bn 12.70 Bn
4 Merck 360.47 Bn 314.85 Bn 12.21 Bn
5 Novartis Ag 302.41 Bn 266.40 Bn 11.24 Bn
6 Astrazeneca 267.36 Bn 241.05 Bn 12.86 Bn
7 Amgen 241.30 Bn 196.70 Bn 7.24 Bn
8 Gilead Sciences 192.97 Bn 167.17 Bn 6.22 Bn
9 Pfizer 171.65 Bn 118.30 Bn 10.94 Bn
10 Allogene Therapeutics 416.10 Mn -685.80 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 293.98 Mn
Mar 31, 2026 236.58 Mn
Dec 31, 2025 198.52 Mn
Sep 30, 2025 214.38 Mn
Jun 30, 2025 220.79 Mn
Mar 31, 2025 237.59 Mn
Dec 31, 2024 217.26 Mn
Sep 30, 2024 240.33 Mn
Jun 30, 2024 273.96 Mn
Mar 31, 2024 333.82 Mn
Dec 31, 2023 365.54 Mn
Sep 30, 2023 396.26 Mn
Jun 30, 2023 337.20 Mn
Mar 31, 2023 361.29 Mn
Dec 31, 2022 455.42 Mn
Sep 30, 2022 477.87 Mn
Jun 30, 2022 394.45 Mn
Mar 31, 2022 364.54 Mn
Dec 31, 2021 283.99 Mn
Sep 30, 2021 293.46 Mn
API Access

Allogene Therapeutics Short-term Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-investments&ticker=ALLO&period=max&api_key=YOUR_API_KEY